Stephen Joyce
Corporate Officer/Principal bei GAMIDA CELL LTD.
Profil
Stephen Joyce is currently the Chief Business Officer at Gamida Cell Ltd.
Prior to this, he held the position of Director-Area Marketing & Market Access at Astellas Pharma Europe Ltd.
from 2016 to 2018.
He also served as the General Manager-Switzerland at Astellas Pharmaceuticals AG in 2018.
Additionally, Mr. Joyce was the SVP, Head-Marketing & Corporate Communications at Amryt Pharma Holdings Ltd.
and Amryt Pharma Plc.
He obtained his undergraduate degree from Trinity College Dublin.
Aktive Positionen von Stephen Joyce
| Unternehmen | Position | Beginn |
|---|---|---|
| GAMIDA CELL LTD. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Stephen Joyce
| Unternehmen | Position | Ende |
|---|---|---|
| AMRYT PHARMA PLC | Public Communications Contact | 01.05.2023 |
| Astellas Pharmaceuticals AG | Corporate Officer/Principal | 01.11.2018 |
Astellas Pharma Europe Ltd.
 Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Corporate Officer/Principal | 01.01.2018 |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Public Communications Contact | - |
Ausbildung von Stephen Joyce
| Trinity College Dublin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GAMIDA CELL LTD. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Health Technology |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Amryt Pharma Plc
 Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Health Technology |
| Astellas Pharmaceuticals AG |
